Pfizer (PFE)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Pfizer | PFE | Healthcare | Drug Manufacturers - General | 79 | 8.1% |
| Current Price ( 3/22 4:03PM EDT) | $40.01 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 60,000.0 | |||
| Sales Growth Forecast | 1.0% | |||
| Net Profit Margin | 29.4% | |||
| Projected Shares Outstanding | 5,500.00 | |||
| EPS - Five year Forecast | $3.38 | |||
| Average P/E Ratio | 15.0 | |||
| Projected Average Price | $50.66 | |||
| Price Appreciation (Annualized) | 4.8% | |||
| Annual Dividend Yield | 3.3% | |||
| Projected Annual Return | 8.1% | |||
| Quality | ||||
| Financial Strength | 95 | 23.7 | ||
| EPS Stability | 68 | 17.0 | ||
| Industry Sales Growth Rate | 4.0% | 3.2 | ||
| Industry Net Profit Margin | 19.3% | 19.0 | ||
| Calculated Quality Rating | 62.9 | |||
| Fool CAPS | ||||
Total Players
5621
Outperforms
593
Underperforms
All-Stars (1109)
1029
Outperforms (93%)
80
Underperforms
|
||||
| Fundamental Data Updated: 01/24/2023 | ||||